Applied dna announces closing of $3.44 million registered direct offering priced at-the-market under nasdaq rules

Stony brook, ny / accesswire / february 2, 2024 / applied dna sciences, inc. (nasdaq:apdn) (applied dna), a leader in pcr-based dna technologies, today announced that it has closed its previously announced registered direct offering of its common stock priced at-the-market under nasdaq rules with certain existing institutional investors (collectively the "holders") for the sale of an aggregate of 5,644,061 of its shares of common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.609 per share. in a concurrent private placement, the company further agreed to issue to the holders unregistered warrants to purchase up to an aggregate of 11,288,122 shares of its common stock.
APDN Ratings Summary
APDN Quant Ranking